NanoEcho has, as one of seven companies, been chosen to participate cost-free in the Smile Incubator and Medicon Village program “10 X Health.” The program provides expertise in business development and focuses on established Life Science companies transitioning from being a startup to becoming a scale-up.
NanoEcho strengthens its position through an agreement with Clinical Trial Consultants for the upcoming clinical phase
NanoEcho announces today that the company has entered an agreement with Clinical Trial Consultants (CTC), who will contribute with expertise, guidance, and preparatory activities for the upcoming clinical registration study.
NanoEcho submits a patent application for an advanced software algorithm for magnetomotive ultrasound
NanoEcho has officially filed a patent application with the Swedish Patent and Registration Office (PRV) for an advanced algorithm designed to enable the use of magnetomotive ultrasound in clinical examinations. The new patent aims to establish strong protection for a software algorithm that continuously calculates, filters, and visualizes clinical examination results in real-time during the use of magnetomotive ultrasound.
Today, NanoEcho enters the formal verification phase of its imaging system, in which ultrasound is used in conjunction with nanoparticles to improve rectal cancer diagnostics. This means that the integration and interaction process has been completed, an internal evaluation of the system’s performance has been made and documentation has been compiled. An independent review process has been carried out to ensure that the documentation complies with the regulatory requirements.
During the past week, NanoEcho exhibited and presented at MEDICA in Düsseldorf, the world’s largest trade fair and event for the MedTech industry with 83,000 visitors.
NanoEcho has been awarded an innovation grant from Vinnova of SEK 99,000 within the scope of business development. The awarded grant is intended to finance a market analysis of potential customer segments.
NanoEcho AB (publ.) has today signed a letter of intent with Peritus Clinic AB in Lund, which includes collaboration in clinical image interpretation related to rectal cancer diagnostics. The initial focus will be on NanoEcho’s upcoming clinical registration study.
NanoEcho has participated in a meeting with international researchers in magnetomotive ultrasound as well as leading colorectal cancer physicians. At the meeting, NanoEcho’s imaging system was presented and discussed and its potential to improve health care for rectal cancer patients.
NanoEcho AB announces today that the name NanoEcho® and the company’s logo have been registered and granted trademark protection in all European Union member states. This dual registration is an important milestone to strengthen NanoEcho’s trademark portfolio and increase the company’s competitiveness ahead of commercial launches.
NanoEcho AB participates in the international ultrasound conference, the IEEE International Ultrasonics Symposium (IUS), together with one of the company’s key suppliers, us4us Ltd. Attendance at the conference is a strategic step toward establishing NanoEcho’s presence in the global ultrasound market.